Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Perinatal Death Within 7 Days
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.0481 | 0.0467 | 0.0496 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0466 | 0.0452 | 0.0481 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.00149 | -0.000614 | 0.00359 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.03 | 0.987 | 1.08 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.03 | 0.986 | 1.08 | log | ClinicalTrials.gov | |
| Number needed to treat, for one more participant with the outcome on Intervention Health Facility Participants than on Control Health Facility Participants | 672 | from the risk difference interval | the interval includes no difference | ClinicalTrials.gov |
Groups 2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Intervention Health Facility Participants | Women/newborn dyads at intervention facilities who registered for labor and delivery, eligible for inclusion, and who provided consent.~Intervention Health Facilities received the WHO Safe Childbirth Checklist Program.~WHO Safe Childbirth Checklist Program: The IHF group will receive the WHO Safe Childbirth Checklist Program designed to maximize likelihood of effective and sustained uptake of the program by birth attendants in the designated facilities. The program includes three key implementation steps that involve: engagement of leadership and clinicians at the state, district, and local levels, a formal launch to introduce the Checklist, and support through peer coaching and data feedback. The intervention facilities will also receive a standardized maternity register to ensure appropriate data collection. | 3,839 | 79,790 | OG000 | ClinicalTrials.gov |
| Group 2 | Control Health Facility Participants | Women/newborn dyads at control health facilities who registered for labor and delivery, eligible for inclusion, and who provided consent.~Matched control facilities provided comparison for intervention facilities. | 3,606 | 77,338 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | SECONDARY | ClinicalTrials.gov |
| Title | Count of Participants With Perinatal Death Within 7 Days | ClinicalTrials.gov |
| Description | Count of participants with perinatal death within 7 days (combined stillbirth or neonatal death) | ClinicalTrials.gov |
| Time frame | 0-7 days | ClinicalTrials.gov |
| Population | There is a discrepancy between the denominator of each primary and secondary outcome because there were a different number of newborns than mothers in the trial. Additionally, we do not have data on every participant for every question. As such, the denominator is specific for each outcome. | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program | ClinicalTrials.gov |
| NCT number | NCT02148952 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Maternal Death, Maternal Morbidity, Stillbirth, Neonatal Death | ClinicalTrials.gov |
| Interventions | WHO Safe Childbirth Checklist Program | ClinicalTrials.gov |
| Lead sponsor | Harvard School of Public Health (HSPH) | ClinicalTrials.gov |
| Results first posted | 2019-02-20 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT02148952?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.